MINERVA RESPIRATORY MEDICINE

Most read articles over the last three weeks

Minerva Respiratory Medicine 2023 December;62(4):155-62
Smoking effects on the pulmonary functions and disease activity in rheumatoid arthritis patients: potential value of anticyclic citrullinated peptide assessed in bronchoalveolar lavage
Hanan M. FATHI, Wafaa Y. ABDEL WAHED, Mohammed M. ABBAS, Radwa A. EL-HEFNY, Enas S. FARHAT *

Minerva Respiratory Medicine 2024 March;63(1):16-24
Bedaquiline and delamanid treatment outcomes among patients with drug-resistant tuberculosis: a systematic review and meta-analysis
Hamid HEIDARI, Safoura MORADKASANI, Roya GHANAVATI, Mahshid KALANTAR-NEYESTANAKI, Ebrahim KOUHSARI, Sobhan GHAFOURIAN, Seifu GIZAW FEYISA, Hossein KAZEMIAN *

Minerva Pneumologica 2002 September;41(3):101-12
Aspirin-intolerance: present clinical and pathogenetical features
Schiavino D., Buonomo A., Nucera E., Patriarca G.

Minerva Respiratory Medicine 2023 September;62(3):108-13
Pulmonary rehabilitation in post COVID-19 syndrome
Amany A. ABOU ZEID, Youssef M. SOLIMAN, Ahmed M. ABD EL-MONEM, Rokaya M. ALLAM, Gihan S. ABO ELWAFA *

Minerva Respiratory Medicine 2022 December;61(4):162-7
Respiratory stimulation physical therapy may improve recovery after thoracoscopic lung cancer resection in senior patients
Liu HU, Xueping LUN, Jiayi HE, Huirong SUN, Huiying HUANG, Siyuan ZHAO, Ximei ZHUANG, Hongjie ZHENG *

Minerva Respiratory Medicine 2023 December;62(4):194-203
Pulmonary rehabilitation in interstitial lung disease
Joshua A. GRIEF, Nima MAKHDAMI, Natya G. RAGHAVAN *

Minerva Pneumologica 2010 September;49(3):161-84
Pathophysiology of non-invasive ventilation in patients with acute respiratory failure
Ferrer M., Torres A.

Minerva Respiratory Medicine 2024 March;63(1):37-48
Obstructive sleep apnea and cancer: epidemiology, pathophysiology, and clinical aspects
Alessandra CASTROGIOVANNI, Domenico M. MODICA, Marta AMATA, Maria R. BONSIGNORE *

Minerva Respiratory Medicine 2023 December;62(4):183-93
Enhancing chronic obstructive pulmonary disease management: long-term noninvasive ventilation, ventilation, holistic treatment, monitoring, and artificial intelligence integration
Maximilian ZIMMERMANN *, Maximilian WOLLSCHING-STROBEL, Doreen KROPPEN, Daniel MAJORSKI, Melanie BERGER, Wolfram WINDISCH, Sarah B. SCHWARZ

Minerva Pneumologica 2004 December;43(4):183-8
Intravenous (iv) azithromycin (AZM)/ ceftriaxone followed by po AZM versus iv lefofloxacin (LEV) followed by po LEV in treatment of hospitalized patients with community-acquired pneumonia
Zervos M., Andrews C., Amsden G., Knirsch C., Swanson R., De Caprariis P., Mandell L.